Prelude Therapeutics, Inc. (PRLD)
4.33
-0.17
(-3.78%)
USD |
NASDAQ |
May 21, 16:00
4.33
0.00 (0.00%)
After-Hours: 17:13
Prelude Therapeutics Market Cap : 344.86M for May 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Myriad Genetics, Inc. | 369.76M |
| Sana Biotechnology, Inc. | 879.40M |
| ACADIA Pharmaceuticals, Inc. | 3.651B |
| Agenus, Inc. | 132.21M |
| Alnylam Pharmaceuticals, Inc. | 40.13B |
Market Cap Related Metrics
| PS Ratio | 19.27 |
| Price to Book Value | 5.730 |
| Price | 4.33 |
| Earnings Yield | -24.42% |